This quarter has been a busy one for Australian cannabis distributor Cann Group (ASX: CAN), evident in the Company’s sales revenue figures increasing a tidy
Little Green Pharma founder and CEO Fleta Solomon. LGP’s focus is on high end pharmaceutical medicines, and it has identified Germany as the most important
An eerie pink light rippled across the cloudy night sky in Mildura on Tuesday night, sending the town’s rumour mill into overdrive. “I read about
It was late 2020 when David decided to talk to his GP about getting a prescription for medicinal cannabis. He’d been diagnosed with fibromyalgia — a
In Australia, the study of cannabis for medical purposes is relatively young. In fact, a recent study on children with cancer receiving palliative care and the
This year’s federal budget announcement has come with a major and welcome surprise for chronic pain sufferers — the inclusion of a new medicinal cannabis
This is a commercial collaboration with Cannatrek. The medicinal properties of the cannabis plant have been known for thousands of years. Yet despite its being used
Australian medicinal cannabis company Australian Natural Therapeutic Group has announced a merger with Canadian Asterion Cannabis and its wholly-owned subsidiary Asterion, with the companies joining
Victorian-headquartered cannabis stock Cann Group (ASX:CAN) has bought its way into Germany’s medicinal cannabis market. In return for a minor investment in German importer and
